Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Turning Point

Turning Point Brands Q3 Net Sales Stagnate YoY, What About Adjusted EBITDA?

Turning Point Brands, Inc. (NYSE: TPB), Q3 2022 net sales decreased 1.9% to $107.8 million compared to 109.9 million in Q3 2021. Q3 2022 Financial Highlights

Benzinga

Key Cannabis Exec Changes You Need To Know About: Turning Point's New CEO, Ayr Wellness' New Pres & More

Turning Point Brand Names New CEO Turning Point Brands, Inc. (NYSE: TPB) has tapped a long-tenured company executive Graham Purdy as CEO and board director following Yavor Efremov's resignation, less than a year following his appointment.

Benzinga

Try These 3 Stocks Ideas for a Golden Retirement

The U.S. market came back in July and early August owing to a robust job market, strong corporate earnings, and a slight decline in inflation. However, the Fed’s hawkish stance to hike the interest rates aggressively until inflation comes down to the target level is expected to keep the market…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga

Holocaust Museum condemns swastika flags outside Turning Point USA summit

TAMPA, Fla. — Calling it “an indefensible act of hatred,” the Florida Holocaust Museum sharply condemned demonstrations at the Tampa Convention Center where a group of neo-fascists waved flags with swastikas outside Turning Point USA’s Student Action Summit.

Tribune News Service

Judicial committee to investigate hiring of controversial law clerk at federal appeals court in Atlanta

ATLANTA — A special committee will investigate the hiring of a law clerk by the chief judge of the federal appeals court in Atlanta in light of allegations the clerk had sent racist and xenophobic texts, a judicial panel ruled Friday.

Tribune News Service

From Hollywood to homeless: The "heart-breaking" downfall of Elswick actor turned addict Jason Hoganson

How crime and drugs destroyed dad's life after movie debut

Chronicle Live

Read news from The Economist, FT, and more,
with one subscription

Turning Point Brands Partners With Marketing Agency Petalfast For Zig-Zag Brand

Turning Point Brands Inc (NYSE:TPB) has partnered with marketing and sales agency Petalfast Inc. for the distribution expansion of its rolling paper brand, Zig-Zag. Turning Point acquired the license to distribute Zig-Zag in North America in 1997. Under the agreement, Petalfast will provide full-service sales and marketing support to Zig-Zag and…

Benzinga

Petalfast Partners With Turning Point Brands To Expand Distribution Of Rolling Paper Brand Zig-Zag

Petalfast Inc., a full-spectrum marketing and sales agency for the cannabis industry, entered into partnership with Turning Point Brands, Inc. (NYSE: TPB), to drive distribution expansion of their iconic rolling paper brand, Zig-Zag

Benzinga

Stigma a hurdle to treatment for addiction

Destigmatising addiction and acknowledging its relationship with trauma would help sufferers get help sooner, says an expert and a recovering heavy drug user.

AAP

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Upgrades

Benzinga

Merger Arbitrage Mondays – Bristol Myers (BMY) Acquires Third Point Therapeutics (TPTX)

Another week and another deal with big pharma buying out a development stage oncology company. Given the real synergies to be had through young companies partnering with big pharma to leverage their manufacturing expertise and distribution networks, regulators have allowed most of them to go through and they tend to…

Benzinga

Biotech buyout: San Diego's Turning Point Therapeutics sells to Bristol Myers Squibb for $4.1 billion

Bristol Myers Squibb has inked a deal to buy San Diego's Turning Point Therapeutics for $4.1 billion in cash, strengthening the pharmaceutical giant's presence in precision cancer treatments.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings for Turning Point

Over the past 3 months, 4 analysts have published their opinion on Turning Point (NASDAQ:TPTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Upgrades

Benzinga

Focus V Nabs Turning Point Canada As Exclusive Distributor, Cannabis Heating Devices Will Benefit

Focus V line of product offerings is now available in Canada, exclusively distributed by Turning Point Brands (NYSE: TPB).

Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Manchester Evening News

'Caring' man, 21, fell from viaduct despite desperate attempts of police officers, inquest hears

'I would like to commend PC Oliver for his actions that day. It’s clear that he’s a very caring officer who tried his best to help Elliot'

The Independent UK

Charlie Kirk’s plans for ‘America First’ school in doubt as contractor pulls out

Turning Point USA online learning academy claimed students were being taught a ‘false narrative about America’

Reason

David Lat on the Crystal Clanton Matter

As usual, Lat puts it very well in his "Original Jurisdiction" Substack newsletter (I've paid for a subscription, and highly recommend it): Last fall, [Chief Judge Pryor] was widely criticized for hiring an allegedly racist law clerk—specifically, Crystal Clanton, now a 3L at George Mason aka Scalia Law. According to…

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.